Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions
Clinical trial NCT02941731 · COMPLETED
Trial details
- NCT number
- NCT02941731
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-09-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.